2,555.00
+152.00
+(6.33%)
At close: January 31 at 2:23:43 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 15 | 15 |
| Avg. Estimate | 2.34B | 1.65B | 7.3B | 7.77B |
| Low Estimate | 2.21B | 1.51B | 7.07B | 7.24B |
| High Estimate | 2.51B | 1.85B | 7.71B | 8.49B |
| Year Ago Sales | 2.37B | 1.67B | 7.43B | 7.3B |
| Sales Growth (year/est) | -1.21% | -1.07% | -1.70% | 6.37% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EA.MX | -- | -- | -- | -- |
| S&P 500 | 10.32% | 10.05% | 13.98% | 13.74% |
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 1/23/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 1/23/2025 |
| Maintains | Roth MKM: Neutral to Neutral | 1/23/2025 |
| Maintains | Stifel: Hold to Hold | 1/23/2025 |
| Maintains | Baird: Outperform to Outperform | 1/23/2025 |
| Downgrade | Raymond James: Outperform to Market Perform | 1/23/2025 |